| Literature DB >> 23822639 |
Marta Rava1, Ismaïl Ahmed, Florence Demenais, Margaux Sanchez, Pascale Tubert-Bitter, Rachel Nadif.
Abstract
BACKGROUND: The identification of gene by environment (GxE) interactions has emerged as a challenging but essential task to fully understand the complex mechanism underlying multifactorial diseases. Until now, GxE interactions have been investigated by candidate approaches examining a small number of genes, or agnostically at the genome wide level. PRESENTATION OF THE HYPOTHESIS: In this paper, we propose a gene selection strategy for investigation of gene-environment interactions. This strategy integrates the information on biological processes shared by genes, the canonical pathways to which they belong and the biological knowledge related to the environment in the gene selection process. It relies on both bioinformatics resources and biological expertise. TESTING THE HYPOTHESIS: We illustrate our strategy by considering asthma, tobacco smoke as the environmental exposure, and genes sharing the same biological function of "response to oxidative stress". Our filtering strategy leads to a list of 28 pathways involving 182 genes for further GxE investigation. IMPLICATIONS OF THE HYPOTHESIS: By integrating the environment into the gene selection process, we expect that our strategy will improve the ability to identify the joint effects and interactions of environmental and genetic factors in disease.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23822639 PMCID: PMC3708788 DOI: 10.1186/1476-069X-12-56
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Figure 1The three-step strategy.
Distribution of the 182 genes by canonical pathways involved in the tobacco smoke metabolism
| NRF2-mediated Oxidative Stress Response | 1.58E-31 | 46 |
| Glutathione Redox Reactions I | 1.26E-25 | 16 |
| Xenobiotic Metabolism Signaling | 6.31E-22 | 44 |
| Aryl Hydrocarbon Receptor Signaling | 3.98E-21 | 32 |
| Mitochondrial Dysfunction | 6.31E-19 | 30 |
| Glutathione-mediated Detoxification | 2.00E-18 | 15 |
| Production of Nitric Oxide and Reactive Oxygen Species in Macrophages | 3.98E-16 | 31 |
| Acute Phase Response Signaling | 2.51E-14 | 28 |
| Antioxidant Action of Vitamin C | 1.58E-12 | 20 |
| IL-8 Signaling | 1.26E-11 | 26 |
| Apoptosis Signaling | 2.95E-09 | 16 |
| Superpathway of Citrulline Metabolism | 4.07E-08 | 7 |
| Superoxide Radicals Degradation | 1.05E-07 | 5 |
| IL-6 Signaling | 1.74E-07 | 16 |
| iNOS Signaling | 2.00E-07 | 10 |
| VEGF Signaling | 1.29E-06 | 13 |
| fMLP Signaling in Neutrophils | 1.95E-06 | 14 |
| Chemokine Signaling | 3.02E-06 | 11 |
| VEGF Family Ligand-Receptor Interactions | 5.50E-05 | 10 |
| NF-KB Signaling | 6.31E-05 | 15 |
| CCR5 Signaling in Macrophages | 1.10E-04 | 9 |
| IL-17A Signaling in Airway Cells | 3.89E-04 | 8 |
| Nucleotide Excision Repair Pathway | 4.07E-04 | 6 |
| IL-1 Signaling | 1.10E-03 | 9 |
| Nicotine Degradation II | 2.82E-03 | 6 |
| Nicotine Degradation III | 7.08E-03 | 5 |
| CCR3 Signaling in Eosinophils | 1.51E-02 | 8 |
| eNOS Signaling | 2.63E-02 | 8 |
*P-values for pathway enrichment testing as calculated by IPA.